<DOC>
	<DOC>NCT00494767</DOC>
	<brief_summary>The drugs GSK189075 and GW869682 result in increased caloric losses. This study is investigating how if taken over 8 weeks that affects weight loss, food intake and the composition of the body. The body composition (fat,water, lean mass) is determined using a new investigational MR technology.</brief_summary>
	<brief_title>Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Inclusion criteria: BMI of 30 40kg/m Females may be included if they are surgically sterile or postmenopausal Exclusion criteria: Change in body weight &gt;4% in the last 3 months History of eating disorders had bariatric surgical intervention for obesity have type I or II diabetes Thyroid disorder not under control Renal or hepatobiliary disease Excessive alcohol consumption Use of drugs of abuse donated of blood in the last 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>body composition</keyword>
	<keyword>hunger</keyword>
	<keyword>weight loss</keyword>
	<keyword>4C model</keyword>
	<keyword>obesity</keyword>
</DOC>